www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/Enzo-Biochem-Says-Favorable-Patent-Appeals-Court-Decision-Will-Allow-Pursuit-of-Claim-for-Substantial-Damages-764494 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwunderlinestyle {text-decoration: underline} --> </style> <!-- sh_cad_1 --> <a href="/aktien/Enzo_Biochem-Aktie">Enzo Biochem</a> Inc. (NYSE:ENZ) said today that a decision ...http://www.finanzen.net/nachricht/Enzo-Biochem-Says-Favorable-Patent-Appeals-Court-Decision-Will-Allow-Pursuit-of-Claim-for-Substantial-Damages-764494http://www.finanzen.net/nachricht/Enzo-Biochem-Announces-Supply-and-Distribution-Agreement-with-Cancer-Genetics-758752 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwunderlinestyle {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Enzo Biochem, Inc. (NYSE:ENZ), a vertically integrated biotechnology company engaged ...http://www.finanzen.net/nachricht/Enzo-Biochem-Announces-Supply-and-Distribution-Agreement-with-Cancer-Genetics-758752http://www.finanzen.net/nachricht/Enzo-Biochem-s-Clinical-Lab-Division-Enters-Exclusive-Agreement-with-Novel-Sequencing-Provider-MultiGEN-Diagnostics-Inc-757106 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwunderlinestyle {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has entered into an agreement ...http://www.finanzen.net/nachricht/Enzo-Biochem-s-Clinical-Lab-Division-Enters-Exclusive-Agreement-with-Novel-Sequencing-Provider-MultiGEN-Diagnostics-Inc-757106http://www.finanzen.net/nachricht/Enzo-Biochem-Reports-Results-for-Second-Fiscal-Quarter-756781 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingbottom3 {padding-bottom: 4.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft1 {padding-left: 5.0px} .bwcellpaddingright0 {padding-right: 0.0px} .bwcellparagraphmargin ...http://www.finanzen.net/nachricht/Enzo-Biochem-Reports-Results-for-Second-Fiscal-Quarter-756781http://www.finanzen.net/nachricht/Enzo-Biochem-Schedules-Teleconference-to-Discuss-Second-Quarter-2010-Results-for-March-15-2010-at-8-30-AM-E-T-755308 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Enzo Biochem, Inc. (NYSE: ENZ), will hold a conference call to discuss its fiscal 2010 second quarter results on Monday, March 15, 2010, at ...http://www.finanzen.net/nachricht/Enzo-Biochem-Schedules-Teleconference-to-Discuss-Second-Quarter-2010-Results-for-March-15-2010-at-8-30-AM-E-T-755308http://www.finanzen.net/nachricht/Enzo-Biochem-Names-Robert-Boorstein-MD-PhD-Medical-Director-of-Enzo-Clinical-Labs-752251 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Enzo_Biochem-Aktie">Enzo Biochem</a> Inc. (NYSE:ENZ) announced today that Robert Boorstein, MD, PhD, an Associate Professor of Pathology ...http://www.finanzen.net/nachricht/Enzo-Biochem-Names-Robert-Boorstein-MD-PhD-Medical-Director-of-Enzo-Clinical-Labs-752251http://www.finanzen.net/nachricht/Enzo-Biochem-Announces-Favorable-Judgment-by-U-S-Patent-Office-in-an-Interference-against-Bayer-HealthCare-for-a-Universal-Diagnostic-Detection-System-750136 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> Enzo Biochem, Inc., (NYSE:ENZ) today announced that the Board of Patent Appeals and Interferences of the United States Patent and Trademark ...http://www.finanzen.net/nachricht/Enzo-Biochem-Announces-Favorable-Judgment-by-U-S-Patent-Office-in-an-Interference-against-Bayer-HealthCare-for-a-Universal-Diagnostic-Detection-System-750136http://www.finanzen.net/nachricht/Enzo-Biochem-is-Well-Positioned-for-New-Paradigms-in-Biotech-and-Healthcare-Annual-Meeting-is-Told-734807 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwunderlinestyle {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Enzo Biochem, Inc. (NYSE: ENZ) is well positioned to benefit from the results of its ...http://www.finanzen.net/nachricht/Enzo-Biochem-is-Well-Positioned-for-New-Paradigms-in-Biotech-and-Healthcare-Annual-Meeting-is-Told-734807http://www.finanzen.net/nachricht/Enzo-Biochem-Reports-That-Its-Clinical-Labs-Division-Has-Available-Newly-Authorized-Swine-Flu-H1N1-Test-726598 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} .bwunderlinestyle {text-decoration: underline} --> </style> <!-- sh_cad_1 --> Enzo Biochem, Inc. (NYSE: ENZ) announced today that its Enzo Clinical Labs division ...http://www.finanzen.net/nachricht/Enzo-Biochem-Reports-That-Its-Clinical-Labs-Division-Has-Available-Newly-Authorized-Swine-Flu-H1N1-Test-726598http://www.finanzen.net/nachricht/Enzo-Biochem-Reports-Sharply-Improved-First-Quarter-Results-714425 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingbottom3 {padding-bottom: 4.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft1 {padding-left: 5.0px} .bwcellpaddingright0 {padding-right: 0.0px} .bwcellparagraphmargin ...http://www.finanzen.net/nachricht/Enzo-Biochem-Reports-Sharply-Improved-First-Quarter-Results-714425